HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideo Saji Selected Research

111indium-DTPA-Ac-TZ14011

5/2006Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideo Saji Research Topics

Disease

60Neoplasms (Cancer)
01/2021 - 01/2003
38Alzheimer Disease (Alzheimer's Disease)
01/2019 - 02/2006
26Amyloid Plaque
10/2018 - 05/2006
15Neoplasm Metastasis (Metastasis)
07/2015 - 01/2003
11Atherosclerotic Plaque (Atheroma)
07/2018 - 09/2004
10Hypoxia (Hypoxemia)
01/2021 - 06/2009
7Prostatic Neoplasms (Prostate Cancer)
02/2019 - 10/2013
5Atherosclerosis
06/2019 - 09/2007
5Infarction (Infarctions)
01/2012 - 02/2006
5Pain (Aches)
02/2009 - 07/2005
4Type 2 Diabetes Mellitus (MODY)
12/2018 - 08/2002
4Myocardial Infarction
07/2018 - 08/2008
4Parkinson Disease (Parkinson's Disease)
12/2017 - 01/2004
3Adenocarcinoma
01/2020 - 03/2014
3Breast Neoplasms (Breast Cancer)
10/2019 - 07/2009
3Rupture
01/2012 - 06/2007
3Thrombosis (Thrombus)
01/2012 - 08/2008
2Insulinoma
01/2021 - 01/2017
2Cognitive Dysfunction
01/2019 - 01/2016
2Dementia (Dementias)
04/2018 - 12/2017
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2016 - 01/2016
2Amyloidosis
04/2014 - 01/2013
2Ischemia
02/2011 - 12/2006
2Body Weight (Weight, Body)
12/2010 - 10/2008

Drug/Important Bio-Agent (IBA)

24Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2011
15Peptides (Polypeptides)IBA
01/2020 - 01/2003
14Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2006
12RadiopharmaceuticalsIBA
01/2018 - 07/2003
10benzofuranIBA
05/2018 - 05/2006
10Matrix Metalloproteinases (MMPs)IBA
12/2015 - 07/2007
9Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2015 - 09/2007
8Monoclonal AntibodiesIBA
10/2020 - 07/2009
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2020 - 09/2014
7Biological ProductsIBA
12/2016 - 03/2004
6AntigensIBA
02/2019 - 10/2013
6oxidized low density lipoproteinIBA
07/2018 - 11/2007
6Fluorescent Dyes (Fluorescent Probes)IBA
01/2017 - 10/2011
6Amyloid beta-PeptidesIBA
07/2010 - 05/2006
5Contrast MediaIBA
12/2016 - 10/2011
5Diphosphonates (Bisphosphonates)IBA
02/2009 - 07/2005
44,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
06/2019 - 04/2012
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019 - 05/2004
4tau Proteins (tau Protein)IBA
01/2019 - 01/2012
4Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2013
4Chalcone (Benzalacetophenone)IBA
10/2018 - 09/2010
4PolymersIBA
01/2018 - 09/2016
4Therapeutic UsesIBA
01/2018 - 11/2006
4Immunoglobulin G (IgG)IBA
11/2015 - 10/2008
4Coloring Agents (Dyes)IBA
09/2015 - 08/2014
4LigandsIBA
03/2014 - 02/2009
41,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2014 - 02/2009
4Pharmaceutical PreparationsIBA
01/2014 - 04/2006
4Oxygen (Dioxygen)IBA
01/2014 - 12/2006
4EnzymesIBA
07/2013 - 08/2003
3Trastuzumab (Herceptin)FDA Link
10/2020 - 01/2017
3Islet Amyloid PolypeptideIBA
12/2018 - 08/2014
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 08/2015
3Molecular Probes (Molecular Probe)IBA
01/2017 - 12/2010
3Immunoglobulin FragmentsIBA
12/2016 - 08/2003
3Peptide Hydrolases (Proteases)FDA Link
08/2014 - 10/2011
3Biotin (Vitamin H)FDA Link
10/2011 - 01/2010
3progelatinaseIBA
10/2011 - 07/2009
3Cell Surface ReceptorsIBA
10/2008 - 11/2007
3Amino AcidsFDA Link
11/2007 - 05/2004
2human ERBB2 proteinIBA
10/2020 - 01/2020
2IntegrinsIBA
01/2020 - 03/2014
2ZincIBA
05/2019 - 02/2006
2Carbonic Anhydrase IXIBA
01/2019 - 01/2018
2Tyrosine Kinase InhibitorsIBA
01/2018 - 04/2017
2Indicators and Reagents (Reagents)IBA
01/2018 - 06/2009
2Radioisotopes (Radionuclides)IBA
01/2018 - 01/2017
2Indium-111IBA
01/2018 - 01/2017
2SynucleinsIBA
12/2017 - 01/2017
2AcidsIBA
01/2017 - 11/2007
2Drug CarriersIBA
03/2016 - 08/2014
2Chemokine ReceptorsIBA
03/2014 - 05/2006
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2014 - 09/2007
2MicellesIBA
01/2014 - 03/2012
2Matrix Metalloproteinase InhibitorsIBA
01/2014 - 07/2007
2QuinoxalinesIBA
07/2013 - 07/2011
2benzimidazoleIBA
06/2013 - 04/2011
2Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2012 - 08/2002
2StreptavidinIBA
12/2011 - 10/2011
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2011 - 02/2011
2Thromboplastin (Tissue Factor)IBA
12/2010 - 08/2008
2CollagenIBA
12/2010 - 10/2008
2auroneIBA
10/2010 - 01/2009
2ChalconesIBA
09/2010 - 10/2009
2LectinsIBA
08/2008 - 11/2007
2Glutamic Acid (Glutamate)FDA Link
11/2007 - 02/2006
2perrhenate (rhenium oxide)IBA
01/2007 - 05/2006
2Glucose (Dextrose)FDA LinkGeneric
04/2006 - 03/2004
2Cholinergic Agents (Cholinergics)IBA
02/2006 - 09/2004
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2006 - 08/2002

Therapy/Procedure

12Therapeutics
01/2018 - 11/2006
8Radiotherapy
01/2019 - 07/2003
5Intravenous Injections
01/2018 - 04/2012
3Intravenous Administration
07/2018 - 12/2009
2Drug Therapy (Chemotherapy)
01/2019 - 01/2014
2Injections
01/2017 - 12/2006